Elona Kogan joins Avanir
This article was originally published in Scrip
Avanir Pharmaceuticals, a biopharmaceutical company specialising in treatments for CNS disorders, has named Elona Kogan vice-president of legal affairs. Ms Kogan has 17 years'experience in legal and regulatory roles, having most recently served as associate general counsel and privacy officer at King Pharmaceuticals.
You may also be interested in...
Almirall has launched its irritable bowel syndrome drug Constella (linaclotide) in six European countries, with several other launches planned for later this year.
Dermira, a dermatology-focused biotech, has raised $35m in a series B financing.
Clovis Oncology has raised its public offering, announced 11 June, from $170m to $240m.